Günter Weingärtner

Title: Innovation in Pharma - The Contributions of Günter Weingärtner

Introduction

Günter Weingärtner, an accomplished inventor based in Seengen, Switzerland, has made significant contributions to the pharmaceutical industry through his innovative research. Notably, he has secured one patent that showcases his expertise in the synthesis of complex compounds used in therapeutic applications.

Latest Patents

Weingärtner's patent, titled "Synthesis of copanlisib and its dihydrochloride salt," presents a novel method for preparing copanlisib, its dihydrochloride form, as well as hydrates of copanlisib dihydrochloride. The invention details innovative intermediate compounds and their applications in efficiently producing copanlisib, which is crucial for various medical therapies. This advancement in the synthesis process highlights his commitment to improving methodologies within the pharmaceutical field.

Career Highlights

Throughout his career, Günter Weingärtner has worked with Bayer Pharma Aktiengesellschaft, a prominent player in the pharmaceutical sector. His role at this esteemed company provides him with access to cutting-edge research and development resources, facilitating his innovative endeavors. Weingärtner's dedication to his work is evident in his impactful inventions, which have potential benefits for many patients requiring novel therapies.

Collaborations

In his professional journey, Günter has collaborated with notable coworkers including Jan-Georg Peters and Philipp Rubenbauer. These partnerships have undoubtedly enriched his research and provided a platform for sharing knowledge and expertise, thus enhancing the overall effectiveness of his innovative projects.

Conclusion

Günter Weingärtner exemplifies the spirit of innovation within the pharmaceutical industry. His patent on the synthesis of copanlisib and its derivatives serves as a testament to his creative problem-solving abilities. With support from Bayer Pharma Aktiengesellschaft and collaboration with fellow researchers, Weingärtner continues to make strides in developing effective medical solutions that can significantly impact healthcare.